Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.

被引：0
|
作者：
vanRhee, AM
Siddiqi, SM
Melman, N
Shi, D
Padgett, WL
Daly, JW
Jacobson, KA
机构：
[1] NIDDK,NIH,LBC,MOL RECOGNIT SECT,BETHESDA,MD 20892
[2] NIDDK,NIH,LBC,PHARMACODYNAM SECT,BETHESDA,MD 20892
来源：
FASEB JOURNAL | 1996年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：784 / 784
页数：1
相关论文
共 50 条
  • [21] Synthetic studies on selective adenosine A2A receptor antagonists. Part II: Synthesis and structure-activity relationships of novel benzofuran derivatives
    Saku, Osamu
    Saki, Mayumi
    Kurokawa, Masako
    Ikeda, Ken
    Uchida, Shin-ichi
    Takizawa, Takuya
    Uesaka, Noriaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3768 - 3771
  • [22] IMIDAZODIAZEPINEDIONES - A NEW CLASS OF ADENOSINE RECEPTOR ANTAGONISTS
    DALY, JW
    HIDE, I
    BRIDSON, PK
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2818 - 2821
  • [23] Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists
    Laversin, Amelie
    Dufossez, Robin
    Bolteau, Raphael
    Duroux, Romain
    Ravez, Severine
    Hernandez-Tapia, Sergio
    Fossart, Martin
    Coevoet, Mathilde
    Liberelle, Maxime
    Yous, Said
    Lebegue, Nicolas
    Melnyk, Patricia
    MOLECULES, 2024, 29 (16):
  • [24] Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists
    Yao, G
    Haque, S
    Sha, L
    Kumaravel, G
    Wang, J
    Engber, TM
    Whalley, ET
    Conlon, PR
    Chang, HX
    Kiesman, WF
    Petter, RC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 511 - 515
  • [25] Inhibition of monoamine oxidase B by selective A2A adenosine receptor antagonists.
    Castagnoli, N
    Petzer, JP
    Castagnoli, K
    Schwarzschild, MA
    Chen, JF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U369 - U369
  • [26] Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.
    Kim, YC
    Jung, KY
    Kim, SK
    Gao, ZG
    Gross, AS
    Melman, N
    Jacobson, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U53 - U53
  • [27] Inhibition of monoamine oxidase B by selective A2A adenosine receptor antagonists.
    Castagnoli, N
    Petzer, JP
    Castagnoli, K
    Schwarzschild, MA
    Chen, JF
    CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (12) : 1663 - 1663
  • [28] 5-Aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists.
    Auberson, YP
    Bischoff, S
    Moretti, R
    Schmutz, M
    Veenstra, SJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (01) : 65 - 70
  • [29] Development of a novel series of EP1 receptor antagonists.
    Breault, GA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U263 - U264
  • [30] Novel P2X7 receptor antagonists.
    Alcaraz, L
    Bent, J
    Bowers, K
    Donald, D
    Fagura, M
    Furber, M
    Laurent, C
    Lawson, M
    Mortimore, M
    McCormick, M
    Robertson, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U45 - U45
12345